SEC Form 4 · accession 0001179110-15-015799
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth H Wilson
Officer — SVP, Sales and Marketing
Period of report
Dec 2, 2015
Accepted (ET)
Dec 4, 2015 · 8:11 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 2, 2015 | F | 1,613 | $27.82 | D | 23,387 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy the reporting person's tax obligations with the vesting of 5,000 restricted stock units ("RSUs") on December 2, 2015.